UPDATED May 04, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SREV | US$1.50 | 0.7% | 2.0% | US$150.2m | n/a | PB2.3x | n/a | n/a | ||
DUOT | US$3.07 | -3.5% | -17.7% | US$22.4m | US$6.50 | PS3x | E85.3% | n/a | ||
PCOR | US$68.14 | -2.8% | 20.9% | US$10.0b | US$83.04 | PS9.9x | E25.9% | n/a | ||
DMRC | US$22.88 | 2.2% | 17.4% | US$486.6m | US$28.00 | PS13.2x | E3.9% | 0% | ||
LVWD | US$0.14 | -17.1% | -18.3% | US$6.2m | n/a | PE29x | n/a | n/a | ||
CXM | US$11.93 | 0% | 6.4% | US$3.2b | US$16.55 | PE62.7x | E27.6% | n/a | ||
RAMP | US$32.56 | -0.2% | 36.8% | US$2.2b | US$47.75 | PS3.4x | E176.3% | n/a | ||
WDAY | US$255.78 | 1.9% | 40.9% | US$67.9b | US$317.33 | PE49.1x | E13.9% | n/a | ||
EPAM | US$242.12 | 1.8% | -0.1% | US$14.0b | US$295.65 | PE33.6x | E13.4% | n/a | ||
AUR | US$3.29 | 8.9% | 125.3% | US$5.1b | US$3.77 | PB2.6x | E13.7% | n/a | ||
AIFS | US$1.50 | 0% | n/a | US$7.0m | n/a | PE34.4x | n/a | 2.3% | ||
ABXX.F | US$9.50 | -1.7% | 89.6% | US$313.8m | n/a | PS1992.2x | n/a | n/a | ||
PAYD | US$1.60 | 6.7% | -5.9% | US$12.9m | n/a | PE36.5x | n/a | n/a | ||
NISN | US$7.72 | 2.6% | 51.3% | US$31.0m | n/a | PE2.1x | n/a | n/a | ||
NCNO | US$30.20 | 2.3% | 35.5% | US$3.5b | US$37.50 | PS7.2x | E97.9% | n/a | ||
RSKD | US$5.23 | 1.0% | 12.2% | US$913.1m | US$5.84 | PS3.1x | E68.9% | n/a | ||
CLBT | US$10.72 | -1.5% | 98.5% | US$2.2b | US$13.64 | PS7.1x | E55.5% | n/a | ||
RDCM | US$9.52 | 9.9% | 0.1% | US$147.3m | US$14.00 | PE39.7x | E36.0% | n/a | ||
DAVA | US$30.90 | 3.6% | -40.7% | US$1.8b | US$49.53 | PE21.1x | E25.0% | n/a | ||
MTLS | US$5.39 | 2.9% | -40.5% | US$318.4m | US$10.34 | PE44.9x | E28.7% | n/a | ||
HUBS | US$600.27 | -4.9% | 35.1% | US$30.6b | US$701.53 | PS14.1x | E49.9% | n/a | ||
OSPN | US$12.39 | 14.8% | -6.3% | US$467.9m | US$13.83 | PS1.9x | E98.4% | n/a | ||
BTCS | US$1.53 | 0% | 24.4% | US$24.0m | US$3.00 | PE3.1x | n/a | n/a | ||
ADBE | US$486.18 | 1.8% | 39.5% | US$217.8b | US$616.89 | PE45.4x | E17.1% | n/a |